What is the Impact Factor of Journal of Scleroderma and Related Disorders?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Journal of Scleroderma and Related Disorders is 1.50, ranking in quartile Q3 of Web of Science (ESCI).

Is Journal of Scleroderma and Related Disorders indexed in Web of Science or Scopus?

Yes, Journal of Scleroderma and Related Disorders is indexed in Web of Science (ESCI, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.631 (Q2) and an H-index of 30.

Who publishes Journal of Scleroderma and Related Disorders and what is the Article Processing Charge (APC)?

Journal of Scleroderma and Related Disorders is published by SAGE. The estimated Article Processing Charge (APC) is approximately $3,043 USD, subject to institutional waivers and corresponding author affiliations.

WoS ESCI Q3Scopus Q2SCImago #9,329Hybrid

Journal of Scleroderma and Related Disorders

Identifier (ISSN):2397-1983(Print)/2397-1991(Online)

•

Publisher:SAGE

Clarivate JCR Index Advisory: Active (ESCI)

Official Website Submission Portal Compare

Clarivate IF (2026)

1.5↑ +0.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS ESCIJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2023–2026)

Clarivate IF trend for Journal of Scleroderma and Related Disorders

WoS Q3

Annual Impact Factor Metric

Current (2026):1.5

Scopus SJR & RankScopus Q2

0.631

#9,329

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

30 papers with at least that number of citations each

WoS: ESCIQ3

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

36articles/year

24.59% Gold OA•74.29% Original Research

Aims & Scope

Journal of Scleroderma and Related Disorders (ISSN: 2397-1983) is a peer-reviewed international scholarly journal in the field of RHEUMATOLOGY, published by SAGE. The periodical holds a Journal Impact Factor (JIF) of 1.50, ranking in quartile Q3 of Web of Science (ESCI), a Scopus SJR indicator of 0.631 (Q2), an H-index of 30.

Topics Covered (Recognized by AI)

Medicine92%Biology81%Internal medicine78.9%Pathology73%Immunology65.4%Psychology44.6%Scleroderma (fungus)41.2%Horticulture41.2%Inoculation41.2%Disease41.2%Surgery39.1%Psychiatry37%Genetics35.3%Radiology28.4%Dermatology23.9%Philosophy21.8%Mathematics21.8%Multiple sclerosis21.5%

Primary Research Areas

Rheumatology

Official Website NLM PubMed Catalog SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRESCI2026

RHEUMATOLOGY

Rank41/58

IndexESCI

JCIESCI2026

RHEUMATOLOGY

Rank49/58

IndexESCI

Category	Index	Rank	Quartile
RHEUMATOLOGY	JCRESCI	41/58	Q3
RHEUMATOLOGY	JCIESCI	49/58	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF1.5

Articles / Year17

Total Citations0

2025

IF1.2

Articles / Year53

Total Citations86

2024

IF1.4

Articles / Year48

Total Citations80

2023

IF2

Articles / Year30

Total Citations153

2022

IF—

Articles / Year38

Total Citations208

Year	Impact Factor	Articles / Year	Total Citations
2026	1.5	17	0
2025	1.2	53	86
2024	1.4	48	80
2023	2	30	153
2022	—	38	208
2021	—	35	369
2020	—	46	731
2019	—	36	678
2018	—	66	750
2017	—	39	1,615
2016	—	34	657
2008	—	1	0

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #9,329Scopus Q2SCImago Profile

Scopus Coverage:2016-2025

•

Scopus Broad Areas:Immunology and MicrobiologyMedicine

Scopus Citation Rank (SJR)Q2

0.631

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

1.38

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,043 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations186

3-Year Documents101

Citable Documents96

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate60.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

RheumatologyQ2

ImmunologyQ3

Immunology and AllergyQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区RHEUMATOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

The journal enforces rigorous peer evaluation with an annual output of approximately 36 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,043 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.